Vanguard Personalized Indexing Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.1K Sell
18,119
-27,935
-61% -$40.3K ﹤0.01% 2168
2026
Q1
$58.5K Buy
+46,054
New +$86.6K ﹤0.01% 2030

Other funds holding HCAT

Vanguard Personalized Indexing Management's HCAT Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Health Catalyst (HCAT) stake by 61% in Q2 2026, selling an estimated $40.3K and leaving 18,119 shares worth $36.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2168.

Vanguard Personalized Indexing Management first reported a position in HCAT in Q1 2026 and has held it in 2 quarters since. The position peaked at $58.5K in Q1 2026. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Vanguard Personalized Indexing Management held 18,119 shares of Health Catalyst worth $36.1K as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 27,935 Health Catalyst shares in Q2 2026, an estimated $40.3K.
  • Health Catalyst made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #2168 holding.
  • Vanguard Personalized Indexing Management first reported a position in Health Catalyst in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Personalized Indexing Management's Health Catalyst position peaked at $58.5K in Q1 2026.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.